Rho, ROCK and actomyosin contractility in metastasis as drug targets
about
Migrastatics-Anti-metastatic and Anti-invasion Drugs: Promises and Challenges.Rho-associated protein kinase 2 (ROCK2): a new target of autoimmunity in paraneoplastic encephalitis.Targeting invasive properties of melanoma cells.Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis.Targeting ROCK activity to disrupt and prime pancreatic cancer for chemotherapy.Quantitative phase imaging unravels new insight into dynamics of mesenchymal and amoeboid cancer cell invasion
P2860
Rho, ROCK and actomyosin contractility in metastasis as drug targets
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Rho, ROCK and actomyosin contractility in metastasis as drug targets
@ast
Rho, ROCK and actomyosin contractility in metastasis as drug targets
@en
Rho, ROCK and actomyosin contractility in metastasis as drug targets
@nl
type
label
Rho, ROCK and actomyosin contractility in metastasis as drug targets
@ast
Rho, ROCK and actomyosin contractility in metastasis as drug targets
@en
Rho, ROCK and actomyosin contractility in metastasis as drug targets
@nl
prefLabel
Rho, ROCK and actomyosin contractility in metastasis as drug targets
@ast
Rho, ROCK and actomyosin contractility in metastasis as drug targets
@en
Rho, ROCK and actomyosin contractility in metastasis as drug targets
@nl
P2860
P3181
P1433
P1476
Rho, ROCK and actomyosin contractility in metastasis as drug targets
@en
P2093
Fanshawe Bruce
Gaia Cantelli
P2860
P3181
P356
10.12688/F1000RESEARCH.7909.1
P407
P577
2016-04-29T00:00:00Z